Share

Our COVID-19 Response Efforts

ohnson & Johnson has been actively engaged in fighting pandemics for over a century. We have done it before, and we will do it again.

With our global reach comes a responsibility and unique ability to leverage our deep scientific expertise and extensive partnerships to take on this challenge. Our more than 130,000 employees around the world are mobilizing with urgency to address the critical needs of families, communities and healthcare providers around the world.

Our commitment to families around the world doesn’t change in a time of crisis: we’ll never stop taking care of you.

Latest announcements on Johnson & Johnson’s efforts to address the pandemic and media resources
Live Video Series
The Road to a Vaccine
In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.
SEASON 2 RETURNS ON JULY 7
How Lessons Learned in Fighting HIV Help Us Battle COVID-19
In the Season 2 premiere, Lisa Ling checks into the virtual AIDS 2020 conference to talk with actress and HIV advocate Laverne Cox, Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., and others about the ongoing quest for an HIV vaccine and how that’s informing research on COVID-19 vaccines.

COVID-19: A Timeline

This is not the first time that a member of the large family of coronaviruses (CoVs) has led to an outbreak of infections among humans. The crises involving severe acute respiratory syndrome (SARS) in China in 2003 and Middle East respiratory syndrome (MERS) in 2012 were both caused by CoVs. J&J is mobilizing resources to find solutions for COVID-19.

December 31, 2019

China alerted the World Health Organization (WHO) to several cases of pneumonia in Wuhan. The virus is unknown.

January 7, 2020

WHO announces they have identified a new virus named 2019-nCoV, also known as Wuhan coronavirus. It is from the CoV family, which includes SARS and the common cold.

January 11, 2020

First death linked to 2019-nCoV.

January 12, 2020

J&J initiates efforts to develop a vaccine candidate against 2019-nCoV and to broadly collaborate with others to screen a library of antiviral molecules.

January 30, 2020

WHO declares the 2019-nCoV outbreak a public health emergency of international concern (PHEIC).

February 1, 2020

First death linked to 2019-nCoV was reported outside of China, in the Philippines.

February 11, 2020

COVID-19 is announced as the official name of the disease caused by novel coronavirus. The virus is named SARS-CoV-2.

February 11, 2020

J&J announces collaboration with U.S. Department of Health & Human Services to accelerate development of a potential COVID-19 vaccine.

February 18, 2020

J&J announces expanded collaboration with U.S. Department of Health & Human Services to accelerate discovery of potential COVID-19 treatments.

February 23, 2020

Europe has its first major outbreak of COVID-19, in the Lombardy region of northern Italy

February 26, 2020

The first case of COVID-19 was reported in South America, marking the spread of the disease to six of seven continents.

March 11, 2020

WHO declares the COVID-19 outbreak a pandemic.

March 27, 2020

J&J announces a $50 million commitment to support frontline health workers battling COVID-19.

March 30, 2020

J&J announces a lead vaccine candidate will move into trials and pledges to supply 1B vaccines worldwide for emergency pandemic use. BARDA and J&J commit $1B to vaccine R&D.

April 23, 2020

J&J enters into a collaboration with Emergent BioSolutions, Inc., to support the manufacturing of its lead investigational COVID-19 vaccine candidate.

June 10, 2020

J&J announces acceleration of its COVID-19 vaccine candidate: Phase 1/2a clinical trial to begin in second half of July.

December 31, 2019

January 7, 2020

January 11, 2020

January 12, 2020

January 30, 2020

February 1, 2020

February 11, 2020

February 11, 2020

February 18, 2020

February 23, 2020

February 26, 2020

March 11, 2020

March 27, 2020

March 30, 2020

April 23, 2020

June 10, 2020

Social Media Updates

  • RT @JanssenGlobal: Tomorrow, 12PM ET join us for a “The Road to a Vaccine” live panel at #AIDS2020. Leaders will discuss the HIV pandemic,…
  • RT @JNJGlobalHealth: In the middle of a pandemic, we’re innovating ways to #endTB. We're joining together with @StopTB, @USAID & @GlobalFun…
  • RT @JanssenGlobal: Join us live at the virtual #AIDS2020 conference, July 7 at 12PM ET for a special live episode of “The Road to a Vaccine…

More From Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue